Real-time · AI · Cross-signal

Monteris Medical just raised. Here's exactly what to do next.

Who to reach, what to say, and why now — on Monteris Medical, plus every funding round, exec hire, and M&A move that follows, each with verified, ICP-ranked contacts.

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Get the full Deep Dive on Monteris Medical — free.

We'll email your report. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.

✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.

✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.

✕Clay enriches lists you built — No live signal of its own, no who or when.

✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.

Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Monteris Medical secures $28 million in Series E funding to accelerate growth in minimally invasive neurosurgery, led by InnovaHealth Partners and Birchview Capital.

PRIVATEMar 12, 2026•3 months ago

Amount Raised

$28 Million

Round Type

series e

MinnetonkaManufacturingBiotechnologyHealthcareHealth CareMedicalMedical Device

Investors

Madryn Asset Management, LpColorado University Healthcare Innovation FundOsf VenturesBirchview Capital, LpInnova Health Partners

Description

Monteris Medical has closed $28 million in Series E equity financing to support its technology innovation program and growth initiatives. The funding will help expand the company's U.S. commercial footprint and accelerate advancements in clinical research. Notable investors include InnovaHealth Partners and Birchview Capital, along with new participants OSF Ventures and the Colorado University Healthcare Innovation Fund.

Company Information

Company

Monteris Medical

Location

131 Cheshire Lane

Minnetonka, Minnesota, United States

About

Monteris Medical is a privately held company that develops and markets innovative MR-guided ablation systems to perform minimally invasive, robotically controlled brain surgery, commonly referred to as laser ablation, LITT (Laser Interstitial Thermal Therapy) or SLA (Stereotactic Laser Ablation). The Monteris NeuroBlate System is the only minimally invasive system that enables a robotic interface for the precise and safe delivery of laser energy. The Monteris Medical NeuroBlate System is a neurosurgical tool and is intended for ablating intracranial soft tissue, including brain structures such as brain tumors, radiation necrosis, and epileptic foci (as identified by non-invasive and invasive neurodiagnostic testing, including imaging). For more information, visit monteris.com.

Related People

Suggested for you

2 contacts

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Monteris Medical's next move

Learn about Strategic plan

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Watching Monteris Medical? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demo Choose your plan